Anti-TRIF (TICAM1) 抗体 [EPR24995-152] (BSA and Azide free) (ab302563)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR24995-152] to TRIF - BSA and Azide free
- Suitable for: WB, IP
- Knockout validated
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-TRIF (TICAM1) antibody [EPR24995-152] (BSA and Azide free)
TRIF 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR24995-152] to TRIF - BSA and Azide free -
由来種
Rabbit -
アプリケーション
適用あり: WB, IPmore details
適用なし: Flow Cyt (Intra),ICC/IF or IHC-P -
種交差性
交差種: Human
非交差種: Mouse, Rat -
免疫原
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: Raji, Ramos, HL-60, HeLa and U-87 MG cell lysate. IP: Raji cell lysate.
-
特記事項
ab302563 is a carrier free version of ab302562.
ab302562 does not react in: WB with mouse and rat samples; IHC-P with human, mouse, and rat specimens; ICC/IF and intracellular flow cytometry with human tissues.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 7.2
Constituent: 100% PBS -
キャリア・フリー
はい -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR24995-152 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab302563の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
Use at an assay dependent concentration. Detects a band of approximately 98 kDa (predicted molecular weight: 76 kDa).
|
|
IP |
Use at an assay dependent concentration.
|
特記事項 |
---|
WB
Use at an assay dependent concentration. Detects a band of approximately 98 kDa (predicted molecular weight: 76 kDa). |
IP
Use at an assay dependent concentration. |
ターゲット情報
-
機能
Involved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively. -
組織特異性
Ubiquitously expressed but with higher levels in liver. -
配列類似性
Contains 1 TIR domain. -
ドメイン
The N-terminal region is essential for activation of the IFNB promoter activity. -
翻訳後修飾
Phosphorylated by TBK1. - Information by UniProt
-
参照データベース
- Entrez Gene: 148022 Human
- Omim: 607601 Human
- SwissProt: Q8IUC6 Human
- Unigene: 29344 Human
-
別名
- IIAE6 antibody
- MGC35334 antibody
- MyD88 3 antibody
see all
画像
-
All lanes : Anti-TRIF (TICAM1) antibody [EPR24995-152] (ab302562) at 1/1000 dilution
Lane 1 : Wild-type U-87 MG cell lysate
Lane 2 : TICAM1 knockout U-87 MG cell lysate
Lane 3 : Raji cell lysate
Lane 4 : HL-60 cell lysate
Lysates/proteins at 20 µg per lane.
Performed under reducing conditions.
Predicted band size: 76 kDa
Observed band size: 85 kDa why is the actual band size different from the predicted?Western blot: Anti-TICAM1 antibody [EPR24995-152] (ab302562) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab302562 was shown to bind specifically to TICAM1. A band was observed at 85 kDa in wild-type U-87 MG cell lysates with no signal observed at this size in TICAM1 knockout cell line. To generate this image, wild-type and TICAM1 knockout U-87 MG cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
-
All lanes : Anti-TRIF (TICAM1) antibody [EPR24995-152] (ab302562) at 1/1000 dilution
Lane 1 : Raji (human Burkitt's lymphoma b lymphocyte) whole cell lysate
Lane 2 : HL-60 (human acute promyelocytic leukemia promyeloblast) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Performed under non-reducing conditions.
Predicted band size: 76 kDa
Observed band size: 98 kDa why is the actual band size different from the predicted?
Exposure time: 59 secondsThis data was developed using ab302562, the same antibody clone in a different buffer formulation.
Diluting and blocking buffer and concentration: 5% NFDM/TBST.
Lysates were freshly made and used for Western Blotting immediately to minimize protein degradation.
Negative control: HL-60. -
All lanes : Anti-TRIF (TICAM1) antibody [EPR24995-152] (ab302562) at 1/1000 dilution
Lane 1 : Ramos (human Burkitt's lymphoma b lymphocyte) whole cell lysate
Lane 2 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Performed under non-reducing conditions.
Predicted band size: 76 kDa
Observed band size: 98 kDa why is the actual band size different from the predicted?
Exposure time: 3 minutesThis data was developed using ab302562, the same antibody clone in a different buffer formulation.
Diluting and blocking buffer and concentration: 5% NFDM/TBST.
Lysates were freshly made and used for Western Blotting immediately to minimize protein degradation.
The identity of the lower MW band at approximately 18 kDa is unknown. -
This data was developed using ab302562, the same antibody clone in a different buffer formulation.
TRIF (TICAM1) was immunoprecipitated from 0.35 mg Raji (human Burkitt's lymphoma b lymphocyte) whole cell lysate with ab302562 at 1/30 dilution (2 µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab302562 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: Raji (human burkitt's lymphoma b lymphocyte) whole cell lysate 10 µg (Input)
Lane 2: ab302562 IP in Raji whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab302562 in Raji whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 minutes
Observed MW (kDa): 98.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
Certificate of Compliance
参考文献 (0)
ab302563 は論文での使用が確認できていません。